Richard J. Hawkins
Director, SciClone Pharmaceuticals (United States).
Companies
- Savara IncBoard member May 5, 2017 to now1
- Plus TherapeuticsBoard member Dec 21, 2007 to now2
- LUMOS PHARMA, INC.Board member Mar 30, 2020 to Dec 13, 20243
- LUMOS PHARMA, INC.Chief executive officer Mar 30, 2020 to Dec 13, 20243
- SciClone Pharmaceuticals (United States)Board member Jun 15, 2006 to Oct 16, 20174
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Savara Inc SVRA161,326 shares5$758.2K at $4.70Dec 9, 2025
Plus Therapeutics CNSY1,529 shares6$2.5K at $1.63Jul 1, 2026- LUMOS PHARMA, INC.0 shares7Dec 12, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 1, 2026Exercised options 922 shares of Plus Therapeutics6
- Dec 9, 2025Granted 40,000 shares of Savara Inc5
- Nov 14, 2025Exercised options 5,860 shares at $1.46 of Savara Inc8
- Jun 20, 2025Bought 48,225 shares at $2.04 of Savara Inc9
- Dec 16, 2024Sold 8,000 shares at $3.32 of Savara Inc10
- Dec 12, 2024Returned to company 4,469 shares of LUMOS PHARMA, INC.7
- Dec 12, 2024Returned to company 753,093 shares of LUMOS PHARMA, INC.7
- Dec 12, 2024Granted 40,000 shares of Savara Inc10
- Sep 13, 2024Bought 4,000 shares at $1.50 of Plus Therapeutics11
- Sep 12, 2024Bought 6,285 shares at $1.35 of Plus Therapeutics12
- May 8, 2024Bought 4,902 shares at $2.04 of Plus Therapeutics13
- Apr 1, 2024Shares withheld for tax 1,522 shares at $2.84 of LUMOS PHARMA, INC.14
- Apr 1, 2024Granted 4,500 shares at $2.84 of LUMOS PHARMA, INC.14
- Feb 1, 2024Shares withheld for tax 690 shares at $3.01 of LUMOS PHARMA, INC.15
- Dec 14, 2023Granted 22,500 shares of Savara Inc16
- Dec 11, 2023Exercised options 10,841 shares at $0.82 of Savara Inc17
- Apr 1, 2023Shares withheld for tax 1,522 shares at $3.31 of LUMOS PHARMA, INC.18
- Mar 3, 2023Bought 1 shares at $1,000.00 of Plus Therapeutics19
- Feb 1, 2023Shares withheld for tax 416 shares at $3.52 of LUMOS PHARMA, INC.20
- Feb 1, 2023Granted 4,500 shares at $3.52 of LUMOS PHARMA, INC.20
- Dec 7, 2022Exercised options 1,172 shares at $0.65 of Savara Inc21
- Sep 23, 2022Bought 208 shares at $8.80 of LUMOS PHARMA, INC.22
- Sep 21, 2022Bought 2,214 shares at $8.84 of LUMOS PHARMA, INC.22
- Sep 20, 2022Bought 1,506 shares at $8.75 of LUMOS PHARMA, INC.23
- Sep 19, 2022Bought 541 shares at $8.65 of LUMOS PHARMA, INC.23
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSavara Inc, Board member
- 2SEC EDGARPlus Therapeutics, Board member
- 3SEC EDGARLUMOS PHARMA, INC., Board member
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Nov 17, 2025
- 9SEC EDGARForm 4 filed Jun 23, 2025
- 10SEC EDGARForm 4 filed Dec 16, 2024
- 11SEC EDGARForm 4 filed Sep 17, 2024
- 12SEC EDGARForm 4 filed Sep 16, 2024
- 13SEC EDGARForm 4 filed May 10, 2024
- 14SEC EDGARForm 4 filed Apr 3, 2024
- 15SEC EDGARForm 4 filed Feb 5, 2024
- 16SEC EDGARForm 4 filed Dec 15, 2023
- 17SEC EDGARForm 4 filed Dec 12, 2023
- 18SEC EDGARForm 4 filed Apr 4, 2023
- 19SEC EDGARForm 4 filed Mar 6, 2023
- 20SEC EDGARForm 4 filed Feb 3, 2023
- 21SEC EDGARForm 4 filed Dec 8, 2022
- 22SEC EDGARForm 4 filed Sep 23, 2022
- 23SEC EDGARForm 4 filed Sep 21, 2022